Logo image of ETB

EATON VANCE T/M BUY-WRT INC (ETB) Stock Price, Quote, News and Overview

NYSE:ETB - New York Stock Exchange, Inc. - US27828X1000 - Currency: USD

14  0 (0%)

Fundamental Rating

3

Taking everything into account, ETB scores 3 out of 10 in our fundamental rating. ETB was compared to 0 industry peers in the Unkown industry. The financial health of ETB is average, but there are quite some concerns on its profitability. ETB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ETB had positive earnings in the past year.
ETB had a positive operating cash flow in the past year.
Of the past 5 years ETB 4 years were profitable.
Of the past 5 years ETB 4 years had a positive operating cash flow.
ETB Yearly Net Income VS EBIT VS OCF VS FCFETB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 18.12%
ROE 18.47%
ROIC 0.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETB Yearly ROA, ROE, ROICETB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ETB's Profit Margin has improved in the last couple of years.
ETB's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of ETB has declined.
Industry RankSector Rank
OM 25%
PM (TTM) 1173.78%
GM 32.16%
OM growth 3Y-1.04%
OM growth 5Y-11.74%
PM growth 3Y-4.11%
PM growth 5Y7.73%
GM growth 3Y-0.34%
GM growth 5Y-9.14%
ETB Yearly Profit, Operating, Gross MarginsETB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

More info and screens

5

2. Health

2.1 Basic Checks

ETB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ETB Yearly Shares OutstandingETB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ETB Yearly Total Debt VS Total AssetsETB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ETB has an Altman-Z score of 34.09. This indicates that ETB is financially healthy and has little risk of bankruptcy at the moment.
ETB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 34.09
ROIC/WACCN/A
WACCN/A
ETB Yearly LT Debt VS Equity VS FCFETB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.43 indicates that ETB may have some problems paying its short term obligations.
ETB has a Quick Ratio of 0.43. This is a bad value and indicates that ETB is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
ETB Yearly Current Assets VS Current LiabilitesETB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.94% over the past year.
ETB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.09% yearly.
ETB shows a decrease in Revenue. In the last year, the revenue decreased by -8.57%.
ETB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.50% yearly.
EPS 1Y (TTM)17.94%
EPS 3Y-3.98%
EPS 5Y1.09%
EPS Q2Q%105.17%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y0.85%
Revenue growth 5Y-4.5%
Sales Q2Q%-8.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETB Yearly Revenue VS EstimatesETB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.32, which indicates a rather cheap valuation of ETB.
Compared to an average S&P500 Price/Earnings ratio of 26.35, ETB is valued rather cheaply.
Industry RankSector Rank
PE 5.32
Fwd PE N/A
ETB Price Earnings VS Forward Price EarningsETB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.34
EV/EBITDA N/A
ETB Per share dataETB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.88
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

ETB has a Yearly Dividend Yield of 9.07%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.42, ETB pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.07%

5.2 History

On average, the dividend of ETB grows each year by 19.51%, which is quite nice.
ETB has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of ETB decreased recently.
Dividend Growth(5Y)19.51%
Div Incr Years1
Div Non Decr Years1
ETB Yearly Dividends per shareETB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

ETB pays out 31.17% of its income as dividend. This is a sustainable payout ratio.
ETB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.17%
EPS Next 2YN/A
EPS Next 3YN/A
ETB Yearly Income VS Free CF VS DividendETB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M
ETB Dividend Payout.ETB Dividend Payout, showing the Payout Ratio.ETB Dividend Payout.PayoutRetained Earnings

More info and screens

EATON VANCE T/M BUY-WRT INC

NYSE:ETB (6/20/2025, 8:04:00 PM)

14

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-26 2025-02-26
Earnings (Next)08-25 2025-08-25
Inst Owners26.8%
Inst Owner Change-7.23%
Ins OwnersN/A
Ins Owner Change0%
Market Cap411.18M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield 9.07%
Yearly Dividend0.62
Dividend Growth(5Y)19.51%
DP31.17%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-16 2025-06-16 (0.1058)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.32
Fwd PE N/A
P/S 62.68
P/FCF 5.34
P/OCF 5.34
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)2.63
EY18.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.62
FCFY18.73%
OCF(TTM)2.62
OCFY18.73%
SpS0.22
BVpS14.22
TBVpS14.22
PEG (NY)N/A
PEG (5Y)4.88
Profitability
Industry RankSector Rank
ROA 18.12%
ROE 18.47%
ROCE 0.39%
ROIC 0.31%
ROICexc 0.31%
ROICexgc 0.31%
OM 25%
PM (TTM) 1173.78%
GM 32.16%
FCFM 1173.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.04%
OM growth 5Y-11.74%
PM growth 3Y-4.11%
PM growth 5Y7.73%
GM growth 3Y-0.34%
GM growth 5Y-9.14%
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 100%
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 34.09
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.94%
EPS 3Y-3.98%
EPS 5Y1.09%
EPS Q2Q%105.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y0.85%
Revenue growth 5Y-4.5%
Sales Q2Q%-8.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.35%
EBIT growth 3Y-0.2%
EBIT growth 5Y-15.72%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.46%
FCF growth 3Y-3.29%
FCF growth 5Y2.87%
OCF growth 1Y18.46%
OCF growth 3Y-3.29%
OCF growth 5Y2.87%